Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Laboratoires Thea has taken over Novartis ophthalmic product portfolio commercialization rights in 30 Countries in Europe, Canada, Mexico and Turkey.
Subscribe to our email newsletter
With this acquisition, Laboratoires Thea is planning to strengthen its geographical presence by establishing new affiliates in countries where the company’s products were either sold through distributors or unavailable to-date.
In addition, the company has already started to build up its sales forces within the new affiliates (Nordic countries, Austria, Turkey, Canada).
As soon as these positions are filled, Laboratoires Thea will have more than 250 medical reps fully dedicated to ophthalmology in Europe.
Laboratoires Thea president Jean-Frederic Chibret said this acquisition represents a major step in their growth strategy and opens numerous cross- fertilization opportunities for both their existing and new businesses.